(Last Updated On: July 13, 2021)
The U.S. Food and Drug Administration on Monday added a warning to the fact sheet for Johnson & Johnson’s COVID-19 vaccine saying that data suggests there is an increased risk of a rare neurological disorder in the six weeks after inoculation.
In a letter to the company, the FDA classified the chances of getting Guillain-Barré syndrome (GBS) after vaccination as being “very low.” Still, it said J&J vaccine recipients should seek medical attention if they have symptoms including weakness or tingling sensations, difficulty walking or difficulty with facial movements.
Around 12.8 million people have received J&J’s one-dose vaccine in the United States. The FDA said 100 preliminary reports of GBS in the vaccine recipients include 95 serious cases that required hospitalization and one reported death.
Olympics-Women s interest in Games on the rise – research report
whbl.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from whbl.com Daily Mail and Mail on Sunday newspapers.
Women s interest in Olympic Games on the rise, says research report
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Onderzoeksbureau: belangstelling van vrouwen voor Spelen groeit – Wel nl
welingelichtekringen.nl - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from welingelichtekringen.nl Daily Mail and Mail on Sunday newspapers.
Women s interest in Games on the rise – research report
ariananews.af - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ariananews.af Daily Mail and Mail on Sunday newspapers.